Investment
Features
FeesSafety
Academy
More
Pluang+

Compare Bangun Kosambi Sukses Tbk. (CBDK) vs UBC Medical Indonesia Tbk. (LABS) Price & Performance

Bangun Kosambi Sukses Tbk.Trade
UBC Medical Indonesia Tbk.Trade

Price performance (Past 24H)

Key statistics

Bangun Kosambi Sukses Tbk. vs UBC Medical Indonesia Tbk. — how do they compare? Bangun Kosambi Sukses Tbk. trades at Rp3,500 (market cap 19.84T), while UBC Medical Indonesia Tbk. trades at Rp146 (market cap 576.7B). The key difference: Bangun Kosambi Sukses Tbk. is far larger — about 34.4× UBC Medical Indonesia Tbk.'s market cap. Which is the better fit depends on your goals.

CBDKLABS
Market Cap
19.84T576.7B

Returns comparison

Trailing returns across standard periods

Top news

Latest headlines on both assets

CBDK
View details
LABS
View details

About Bangun Kosambi Sukses Tbk.

PT Bangun Kosambi Sukses Tbk (the Company) was established based on Notarial Deed No. 01 of Djedjem Widjaja, S.H., M.H., dated 3 April 2000. The Company commenced its commercial operations in 2020. The Company is controlled by its immediate parent company, PT Pantai Indah Kapuk Dua Tbk, domiciled in Jakarta and its ultimate parent companies are PT Agung Sedayu and PT Tunas Mekar Jaya, domiciled in Jakarta.

Read more on CBDK

About UBC Medical Indonesia Tbk.

PT UBC Medical Indonesia (the Company) was established under the framework of Law of the Republic of Indonesia No. 20 year 1994 concerning the Foreign Capital Investment, as amended by Law No. 25 year 2007 concerning the Capital Investment based on Notarial Deed No. 01 dated 4 June 2014 of Novita Puspitarini, S.H., Notary in Jakarta. The Company started its commercial activities in October 2014. The parent entity as well as the ultimate parent entity of the Company is PT Optel Investama Mulia.

Read more on LABS